Warning signs include: Severe, persistent abdominal pain that may radiate to the back Nausea and vomiting that does not resolve Abdominal tenderness or distension Patients experiencing these symptoms should discontinue tirzepatide immediately and seek emergency medical evaluation
It contrasts that with peptide medications like semaglutide and tirzepatide, which bind those receptors and produce sustained systemic effects on appetite, gastric motility, and insulin secretion
recruited 1961 non-diabetic adults with a BMI of 30 kg/m 2 (or 27 kg/m 2 with more than 1 body weight-related coexisting disease)
Conclusions In this real-world, retrospective, observational study, adults with sub-optimally controlled T2D on GLP-1 RA therapy, initiating use of FSL, resulted in a significant improvement in A1c levels after 6 months of CGM use
Private Label & Wholesale Program
doi: 10.1016/0891-5849(94)90030-2